Literature DB >> 30095537

Visual Snow: Visual Misperception.

Owen B White1, Meaghan Clough, Allison M McKendrick, Joanne Fielding.   

Abstract

BACKGROUND: Visual snow (VS) is a constant visual disturbance described as flickering dots occupying the entire visual field. Recently, it was characterized as the defining feature of a VS syndrome (VSS), which includes palinopsia, photophobia, photopsias, entoptic phenomena, nyctalopia, and tinnitus. Sixty percent of patients with VSS also experience migraine, with or without aura. This entity often is considered psychogenic in nature, to the detriment of the patient's best interests, but the high frequency of similar visual symptoms argues for an organic deficit. The purpose of this review is to clarify VSS as a true entity and elaborate the nature of individual symptoms and their relationship to each other. EVIDENCE ACQUISITION: The literature was reviewed with specific regard to the clinical presentation and psychophysical, neurophysiological, and functional imaging studies in patients with defined visual disturbances that comprise VSS.
RESULTS: Consideration of the individual symptoms suggests that multiple factors are potentially involved in the development of VSS, including subcortical network malfunction and cortical hyperexcitation. Although there is substantial overlap between VSS and migraine syndromes in terms of co-occurring symptoms, both neurophysiological and neuroimaging studies provide substantial evidence of separate abnormalities of processing, supporting these as separate syndromes.
CONCLUSIONS: VSS is likely associated with either hyperactive visual cortices or, alternatively, impaired processing of simultaneous afferent information projecting to cortex. VSS likely results from widespread disturbance of sensory processing resulting in sensory misperception. There may be a number of syndromes associated with impaired sensory processing resulting in sensory misperception, including migraine, persistent perceptual postural dizziness, and tinnitus, which overlap with VSS. Elucidation of abnormality in one defined syndrome may provide a path forward for investigating all.

Entities:  

Mesh:

Year:  2018        PMID: 30095537     DOI: 10.1097/WNO.0000000000000702

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  8 in total

1.  Visual snow syndrome: evolving neuro-optometric considerations in concussion/mild traumatic brain injury.

Authors:  Kenneth J Ciuffreda; Mh Esther Han; Barry Tannen; Daniella Rutner
Journal:  Concussion       Date:  2021-04-09

Review 2.  Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: A narrative review.

Authors:  Antonia Klein; Christoph J Schankin
Journal:  Headache       Date:  2021-09-27       Impact factor: 5.311

Review 3.  Retinal migraine.

Authors:  Bogdan Marius Istrate; Crisanda Vîlciu; Carmen Răgan
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

Review 4.  Symptoms related to the visual system in migraine.

Authors:  Robin M van Dongen; Joost Haan
Journal:  F1000Res       Date:  2019-07-30

5.  Persistent Postural-Perceptual Dizziness: Precipitating Conditions, Co-morbidities and Treatment With Cognitive Behavioral Therapy.

Authors:  John Waterston; Luke Chen; Kate Mahony; Jamila Gencarelli; Geoff Stuart
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

Review 6.  Visual Snow: Updates on Pathology.

Authors:  Clare L Fraser
Journal:  Curr Neurol Neurosci Rep       Date:  2022-03-02       Impact factor: 5.081

7.  Cortical oscillatory dysrhythmias in visual snow syndrome: a magnetoencephalography study.

Authors:  Jenny L Hepschke; Robert A Seymour; Wei He; Andrew Etchell; Paul F Sowman; Clare L Fraser
Journal:  Brain Commun       Date:  2021-12-18

8.  Editorial: Visual Snow: Old Problem, New Understanding.

Authors:  Owen B White; Joanne Fielding; Victoria Susan Pelak; Christoph J Schankin
Journal:  Front Neurol       Date:  2022-04-15       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.